<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36407125</PMID><DateRevised><Year>2023</Year><Month>01</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2666-7762</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><PubDate><Year>2023</Year><Month>Jan</Month></PubDate></JournalIssue><Title>The Lancet regional health. Europe</Title><ISOAbbreviation>Lancet Reg Health Eur</ISOAbbreviation></Journal><ArticleTitle>Pharmacological trials for long COVID: first light at the end of the tunnel.</ArticleTitle><Pagination><StartPage>100544</StartPage><MedlinePgn>100544</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">100544</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.lanepe.2022.100544</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Buonsenso</LastName><ForeName>Danilo</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro di Salute Globale, Universit&#xe0; Cattolica del Sacro Cuore, Roma, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>11</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Lancet Reg Health Eur</MedlineTA><NlmUniqueID>101777707</NlmUniqueID><ISSNLinking>2666-7762</ISSNLinking></MedlineJournalInfo><CoiStatement>Danilo Buonsenso has received a grant from 10.13039/100004319Pfizer to study the long-term burden of Long Covid in Children, and a grant from RocheItalia to study microRNA profile in children with Long Covid. Danilo Buonsenso has partecipated in a Peer-to-Peer educational program on Long Covid sponsored by 10.13039/100004319Pfizer.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>10</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>10</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>11</Month><Day>22</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>21</Day><Hour>4</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>11</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36407125</ArticleId><ArticleId IdType="pmc">PMC9647474</ArticleId><ArticleId IdType="doi">10.1016/j.lanepe.2022.100544</ArticleId><ArticleId IdType="pii">S2666-7762(22)00240-X</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Global Burden of Disease Long COVID Collaborators. Wulf Hanson S., Abbafati C., et al. Estimated global proportions of individuals with persistent fatigue, cognitive, and respiratory symptom clusters following symptomatic COVID-19 in 2020 and 2021. JAMA. 2022;328(16):1604&#x2013;1615. doi: 10.1001/jama.2022.18931.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.18931</ArticleId><ArticleId IdType="pmc">PMC9552043</ArticleId><ArticleId IdType="pubmed">36215063</ArticleId></ArticleIdList></Reference><Reference><Citation>Cutler D.M. The costs of long COVID. JAMA Health Forum. 2022;3(5) doi: 10.1001/jamahealthforum.2022.1809.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamahealthforum.2022.1809</ArticleId><ArticleId IdType="pubmed">36219031</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D., Gualano M.R., Rossi M.F., et al. Post-acute COVID-19 sequelae in a working population at one year follow-up: a wide range of impacts from an Italian sample. Int J Environ Res Public Health. 2022;19(17) doi: 10.3390/ijerph191711093.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph191711093</ArticleId><ArticleId IdType="pmc">PMC9518581</ArticleId><ArticleId IdType="pubmed">36078808</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters C., Dulon M., Westermann C., Kozak A., Nienhaus A. Long-term effects of COVID-19 on workers in health and social services in Germany. Int J Environ Res Public Health. 2022;19(12):6983. doi: 10.3390/ijerph19126983.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph19126983</ArticleId><ArticleId IdType="pmc">PMC9222999</ArticleId><ArticleId IdType="pubmed">35742231</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansen K.S., Mogensen T.H., Agergaard J., et al. High-dose coenzyme Q10 therapy versus placebo in patients with post COVID-19 condition: a randomized, phase 2, crossover trial. Lancet Reg Health Eur. 2022 doi: 10.1016/j.lanepe.2022.100539.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2022.100539</ArticleId><ArticleId IdType="pmc">PMC9627534</ArticleId><ArticleId IdType="pubmed">36337437</ArticleId></ArticleIdList></Reference><Reference><Citation>Davies M. Long covid patients travel abroad for expensive and experimental &#x201c;blood washing&#x201d;. BMJ. 2022;378:o1671. doi: 10.1136/bmj.o1671.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.o1671</ArticleId><ArticleId IdType="pubmed">35820689</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D., Di Gennaro L., De Rose C., et al. Long-term outcomes of pediatric infections: from traditional infectious diseases to long Covid. Future Microbiol. 2022;17:551&#x2013;571. doi: 10.2217/fmb-2022-0031.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/fmb-2022-0031</ArticleId><ArticleId IdType="pmc">PMC8910780</ArticleId><ArticleId IdType="pubmed">35264003</ArticleId></ArticleIdList></Reference><Reference><Citation>Couzin-Frankel J. Clues to long COVID. Science. 2022;376(6599):1261&#x2013;1265. doi: 10.1126/science.add4297.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.add4297</ArticleId><ArticleId IdType="pubmed">35709281</ArticleId></ArticleIdList></Reference><Reference><Citation>Murga I., Aranburu L., Gargiulo P.A., G&#xf3;mez Esteban J.C., Lafuente J.V. Clinical heterogeneity in ME/CFS. A way to understand long-COVID19 fatigue. Front Psychiatry. 2021;12 doi: 10.3389/fpsyt.2021.735784.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyt.2021.735784</ArticleId><ArticleId IdType="pmc">PMC8542754</ArticleId><ArticleId IdType="pubmed">34707521</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D., Munblit D., Pazukhina E., et al. Post-COVID condition in adults and children living in the same household in Italy: a prospective cohort study using the ISARIC global follow-up protocol. Front Pediatr. 2022;10 doi: 10.3389/fped.2022.834875.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2022.834875</ArticleId><ArticleId IdType="pmc">PMC9070551</ArticleId><ArticleId IdType="pubmed">35529336</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>